US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

237.45

-1.2830-0.54%

Post-market: 237.580.1269+0.05%19:30 EDT

Volume:11.62K

Turnover:2.76M

Market Cap:474.08M

PE:- -

High:238.35

Open:238.12

Low:236.49

Close:238.74

52wk High:246.55

52wk Low:171.63

Shares:2.00M

Float Shares:2.00M

Volume Ratio:0.98

T/O Rate:0.58%

Dividend:0.95

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Vertex Pharmaceuticals Incorporated : Leerink Partners Resumes Coverage with Outperform Rating; Target Price $594

THOMSON REUTERS

Sino Biopharmaceutical Stock Rises 8.2% in Hong Kong, Outperforms Competitors

Correction to Vertex Material Listing Article on Sept. 17

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Vertex wins approval for 24/7 underground operations at Reward Gold Mine

Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)

Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock

Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

Revolution Medicines gets orphan designation for pancreatic cancer treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BBH/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":237.4531,"timestamp":1790971200000,"preClose":238.7361,"halted":0,"volume":11617,"hourTrading":{"tag":"盘后","latestPrice":237.58,"preClose":237.4531,"latestTime":"19:30 EDT","volume":23,"amount":5462.9441,"timestamp":1790983804584,"change":0.1269,"changeRate":0.000534,"amplitude":0},"delay":0,"changeRate":-0.0053741348710982005,"floatShares":1996503,"shares":1996503,"eps":0,"marketStatus":"Market Closed","change":-1.283,"latestTime":"10-02 16:00:00 EDT","open":238.115,"high":238.345,"low":236.49,"amount":2757782.5154899997,"amplitude":0.00777,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":238.7361,"sharesOutstanding":1976503,"nav":237.39591,"aum":476335613.78,"dividendRate":0.004017,"bidAskSpread":0.001118,"preHourTrading":{"tag":"盘前","latestPrice":238.7361,"preClose":238.7361,"latestTime":"08:20 EDT","volume":1,"amount":238.7361,"timestamp":1790943636127,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":237.58,"preClose":237.4531,"latestTime":"19:30 EDT","volume":23,"amount":5462.9441,"timestamp":1790983804584,"change":0.1269,"changeRate":0.000534,"amplitude":0},"volumeRatio":0.9753333052126362,"impliedVol":0.1958,"impliedVolPercentile":0.4661},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":1996503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9753333052126362,"shares":1996503,"dividePrice":0.9538,"high":238.345,"amplitude":0.00777,"preClose":238.7361,"low":236.49,"week52Low":171.63,"pbRate":"--","week52High":246.55,"institutionHeld":0,"latestPrice":237.4531,"eps":0,"divideRate":0.004017,"volume":11617,"delay":0,"ttmEps":0,"open":238.115,"prevYearClose":189.2649,"prevWeekClose":245.36,"prevMonthClose":244.575,"prevQuarterClose":244.575,"fiveDayClose":245.36,"twentyDayClose":243.7291,"sixtyDayClose":210.1281},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669315293","title":"Vertex Pharmaceuticals Incorporated : Leerink Partners Resumes Coverage with Outperform Rating; Target Price $594","url":"https://stock-news.laohu8.com/highlight/detail?id=2669315293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669315293?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:03","pubTimestamp":1789985027,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45A0U1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","LU2456880835.USD","LU0109394709.USD","LU0061475181.USD","LU2362540622.SGD","LU2462157665.USD","TBXU","BK4567","LU2468319806.SGD","LU1093756325.SGD","LU0320765992.SGD","LU2236285917.USD","LU0058720904.USD","LU2362541273.HKD","LU1093756168.USD","IBBQ","LU1585245621.USD","LU0289739699.SGD","IDNA","PBE","IE00BJJMRZ35.SGD","GNMX","LU0823416689.USD","IE00BZ9MQY76.HKD","BK4139","LU1674673428.USD","LU2324357040.USD","LU2362541513.USD","BIB","LU0234570918.USD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","BK4532","IE00B894F039.SGD","IE00BFTCPJ56.SGD","LU1035775433.USD","IBB","SG9999001176.SGD","BBH","IE00BJT1NW94.SGD","LU0256863811.USD","BK4588","LU1069344957.HKD","LU2417539215.USD","VRTX","LU1778281490.HKD","BK4533","LU2089984988.USD","SG9999013999.USD","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669156720","title":"Sino Biopharmaceutical Stock Rises 8.2% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669156720","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669156720?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:30","pubTimestamp":1789979400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 8.2% to 5.92 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.2% to 25042.71.Sino Biopharmaceutical Ltd. closed 32% below its 52-week high of HK$8.65, which the company achieved Sept. 22.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 7.6% and Amgen Inc. remained unchanged.Trading volume totaled 150.2 million shares, compared to the 50-day average of 89.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","IBB","IE0009355771.USD","LU2242646821.SGD","LU0889565916.HKD","IE00B2B36J28.USD","LU0109394709.USD","LU2468319806.SGD","LU2089984988.USD","AMGN","LU1057294990.SGD","LU1571399168.USD","BBH","BK4139","LU1983299246.USD","LU0868494617.USD","TBXU","BK4581","HK0000165453.HKD","IE0002141913.USD","BK1191","IE00BZ08YT58.USD","LU2112291526.USD","LU2242652126.USD","BK4534","SG9999001440.SGD","BK4599","BK1589","IE00BZ08YR35.GBP","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE00BZ08YS42.EUR","PBE","IE00BJT1NW94.SGD","BK4566","BK4533","LU1023059063.AUD","01177","LU0058720904.USD","IBBQ","LU0122379950.USD","BK1521","BIB","BK1515","BK4588","IE00B4R5TH58.HKD","LU0289739699.SGD","LU0320765992.SGD","LU1061106388.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669412132","title":"Correction to Vertex Material Listing Article on Sept. 17","url":"https://stock-news.laohu8.com/highlight/detail?id=2669412132","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669412132?lang=en_us&edition=fundamental","pubTime":"2026-09-21 12:48","pubTimestamp":1789966080,"startTime":"0","endTime":"0","summary":"Tan Chin Teong is the founder and technical director of Vertex Material. \"Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing,\" at 0931 GMT on Sept. 17, misstated the name as Tan Chin Tong.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU0823416689.USD","IE00B19Z9Z06.USD","SGXZ57979304.SGD","IDNA","LU0889565916.HKD","TBXU","BK4588","LU2362541513.USD","LU1035775433.USD","LU2462157665.USD","LU0079474960.USD","LU0256863811.USD","LU1778281490.HKD","VRTX","LU1093756168.USD","PBE","IE00B19Z3B42.SGD","BK4567","LU2324357040.USD","SG9999001176.USD","SG9999013999.USD","IE00B19Z9P08.USD","LU0417517546.SGD","LU0566484027.USD","IE00BFTCPJ56.SGD","LU2236285917.USD","SG9999001176.SGD","LU2362540622.SGD","LU0234570918.USD","LU1585245621.USD","IBB","LU2089984988.USD","BIB","LU0058720904.USD","LU1069344957.HKD","GNMX","LU0320765992.SGD","IBBQ","BK4023","VERX","LU2468319806.SGD","LU2362541273.HKD","LU0109394709.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1093756325.SGD","IE00BJJMRZ35.SGD","IE00B894F039.SGD","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973164","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973164","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973164?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:34","pubTimestamp":1789763640,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rallied 1.55% to $385.65 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.17% to 7,650.50 and the Dow Jones Industrial Average  falling 0.18% to 51,682.64.This was the stock's third consecutive day of gains.Amgen Inc. closed 13.73% below its 52-week high of $447.03, which the company reached on August 25th.The stock outperformed some of its competitors Friday, as Johnson & Johnson  fell 0.09% to $269.99, Pfizer Inc.  rose 0.07% to $27.66, and AbbVie Inc.  fell 0.02% to $263.96.Trading volume  eclipsed its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 18, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","BBH","LU0109394709.USD","LU0868494617.USD","BK4566","LU1057294990.SGD","LU0122379950.USD","LU0889565916.HKD","BK4599","BK4534","LU2112291526.USD","BK4588","IE0002141913.USD","IE00BJJMRZ35.SGD","PJP","PBE","IBB","SG9999001440.SGD","BK4585","LU1983299246.USD","04332","BK4139","BK4533","TBXU","IBBQ","LU0289739699.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","AMGN","LU1571399168.USD","BK4581","LU2468319806.SGD","LU0320765992.SGD","LU1023059063.AUD","BIB","LU2089984988.USD","LU2242652126.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668914913","title":"Vertex wins approval for 24/7 underground operations at Reward Gold Mine","url":"https://stock-news.laohu8.com/highlight/detail?id=2668914913","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668914913?lang=en_us&edition=fundamental","pubTime":"2026-09-18 08:18","pubTimestamp":1789690694,"startTime":"0","endTime":"0","summary":"An announcement from Vertex Minerals Ltd. ( ($AU:VTX) ) is now available. Vertex Minerals has secured a varied Environment Protection License from ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU1430594728.SGD","IE00B19Z9Z06.USD","LU0432979614.USD","SGXZ57979304.SGD","IE0009355771.USD","LU0109394709.USD","IE0002270589.USD","LU0079474960.USD","LU2362540622.SGD","LU2462157665.USD","TBXU","BK4567","LU2468319806.SGD","LU1559883803.SGD","LU2236285917.USD","LU0058720904.USD","LU2237438978.USD","IBBQ","LU0289739699.SGD","IDNA","PBE","SG9999001176.USD","VERX","GNMX","IE0002141913.USD","IE00BZ9MQY76.HKD","LU0757428866.USD","BK4139","LU2324357040.USD","BK4585","LU2362541513.USD","BIB","LU1815336091.USD","IE00BFTCPJ56.SGD","BK4532","IE00B894F039.SGD","LU1035775433.USD","LU1674673691.USD","IBB","SG9999001176.SGD","BBH","IE00BJT1NW94.SGD","LU1069344957.HKD","VRTX","LU1778281490.HKD","BK4533","LU2089984988.USD","SG9999013999.USD","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668990195","title":"Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2668990195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668990195?lang=en_us&edition=fundamental","pubTime":"2026-09-18 06:33","pubTimestamp":1789684401,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has provided an announcement. Vortex Energy Corp. has entered into an asset purchase agreement to acquire the M...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","IE00BZ9MQY76.HKD","SG9999001176.USD","LU0889565916.HKD","LU1674673428.USD","LU2362541273.HKD","LU2236285917.USD","IE00B2B36J28.USD","LU0109394709.USD","BK4532","LU2468319806.SGD","BBH","BK4139","BK4567","LU1430594728.SGD","LU0417517546.SGD","LU0256863811.USD","TBXU","LU0061475181.USD","LU0823416689.USD","SGXZ57979304.SGD","SG9999013999.USD","LU1585245621.USD","LU2237438978.USD","IDNA","LU2417539215.USD","IE00BFTCPJ56.SGD","GNMX","IE00B19Z3B42.SGD","PBE","IE0002270589.USD","LU1069344957.HKD","IE00BJT1NW94.SGD","LU0432979614.USD","LU1093756325.SGD","LU2324357040.USD","LU2462157665.USD","IE00B894F039.SGD","LU0058720904.USD","IBBQ","SG9999001176.SGD","VRTX","IE00B19Z9Z06.USD","BIB","LU0079474960.USD","BK4588","IE00B4R5TH58.HKD","LU2362541513.USD","LU2456880835.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992198","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992198","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992198?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:34","pubTimestamp":1789677240,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rose 2.17% to $150.89 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.14% to 7,637.76 and the Dow Jones Industrial Average  rising 0.61% to 51,778.04.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 4.07% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  rose 1.10% to $270.22, Pfizer Inc.  rose 0.66% to $27.64, and Abbott Laboratories  fell 0.13% to $102.23.Trading volume  eclipsed its 50-day average volume of 6.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 17, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0234570918.USD","LU1778281490.HKD","BK4532","BK4568","LU0109394709.USD","LU1057294990.SGD","LU1839511570.USD","LU1934455277.USD","LU0889565916.HKD","LU0965508806.USD","LU2087621335.USD","LU1585245621.USD","BMED","LU0965509010.AUD","LU1571399168.USD","LU0965509283.SGD","BK4583","LU2468319806.SGD","LU1674673428.USD","LU0058720904.USD","LU2089984988.USD","SG9999015945.SGD","LU0861579265.USD","TMED","LU1066053197.SGD","LU1066051498.USD","IE00BSNM7G36.USD","IE00B19Z3581.USD","BK4139","BK4588","BBH","SG9999015986.USD","IBB","BIB","IE00BKVL7J92.USD","LU2112291526.USD","IE0002270589.USD","IBBQ","LU1037948541.HKD","LU0289739699.SGD","IE00BZ1G4Q59.USD","LU1037948897.HKD","IE00B7SZLL34.SGD","LU1934455863.HKD","LU0823416689.USD","TBXU","LU0882574055.USD","LU2324357040.USD","LU1674673691.USD","LU1934455194.USD","MEDI","BK4585","LU1430594728.SGD","LU2357627491.SGD","LU0859254822.USD","LU0965509101.SGD","BK4578","SG9999015952.SGD","SG9999015978.USD","IE00B3T34201.USD","BK4550","GILD","LU1023059063.AUD","BK4566","IE00B19Z3B42.SGD","LU0114720955.EUR","LU1061106388.HKD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992940","title":"Moderna Inc. Stock Climbs 8.5%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992940","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992940?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:33","pubTimestamp":1789677180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 8.5% to $158.07 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.7% to 26,418.30 and the Dow Jones Industrial Average rising 0.6% to 51,778.04.This was the stock's second consecutive day of gains.Moderna Inc. closed 10.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.22, Pfizer Inc. rose 0.7% to $27.64, and Gilead Sciences Inc. rose 2.17% to $150.89.Trading volume totaled 19.1 million, compared to the 50-day average of 17.3 million.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","BK4534","GNOM","LU0289739699.SGD","LU1585245621.USD","MEDI","LU1061106388.HKD","BBH","LU0122379950.USD","LU1839511570.USD","LU0859254822.USD","IDNA","IBBQ","LU0861579265.USD","BK4568","BK4501","BK4551","LU1674673428.USD","LU0889565916.HKD","LU1934455863.HKD","LU2089984988.USD","MRNA","GILD","MRNX","BK4566","BMED","LU0114720955.EUR","LU2324357040.USD","LU2357627491.SGD","BIB","IE00BSNM7G36.USD","LU0882574055.USD","IE00B19Z3581.USD","TBXU","LU0965509101.SGD","LU0320765992.SGD","TMED","IBB","LU0965509010.AUD","LU1778281490.HKD","LU0234570918.USD","BK4578","SG9999015945.SGD","IE00B7SZLL34.SGD","SG9999015986.USD","MRNY","LGHT","LU0823416689.USD","LU1037948897.HKD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668993629","title":"Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668993629","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668993629?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662630,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is running a Phase 3 study testing romiplostim plus predni...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","ITP","PJP","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4581","IBBQ","BK4534","IE0002141913.USD","PBE","LU0109394709.USD","BK4199","BIB","BBH","LU2089984988.USD","IBB","LU1061106388.HKD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4588","LU0320765992.SGD","LU1571399168.USD","LU2468319806.SGD","IE0009355771.USD","SG9999001440.SGD","LU2242646821.SGD","BK4599","LU0122379950.USD","LU0868494617.USD","LU0289739699.SGD","LU1057294990.SGD","IE00B4R5TH58.HKD","BK4533","BK4585","LU2112291526.USD","LU2242652126.USD","LU1983299246.USD","AMGN","LU1023059063.AUD","TBXU","LU0889565916.HKD","BK4139","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668962770","title":"Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668962770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668962770?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:40","pubTimestamp":1789648810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Charles River Labs (CRL) and Amgen (AMGN) with bulli...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4137","LABU","BK4581","LU2468319806.SGD","IE0009355771.USD","XBI","BK4121","LU0128526141.USD","LU1815336091.USD","XLV","BIB","BK4530","AMGN","IE00B4R5TH58.HKD","LU0029874061.USD","BK4585","BK4588","HCSG","IE00BFMHRM44.USD","IBB","IE00BJJMRZ35.SGD","LU2112291526.USD","LU1057294990.SGD","IE0002141913.USD","IE00B2B36J28.USD","PBE","LU2242646821.SGD","BK4533","LU0289739699.SGD","IE00BJT1NW94.SGD","LU0757428866.USD","SG9999001440.SGD","LU1061106388.HKD","PJP","BK4534","BK4566","BK4599","IBBQ","LU0058720904.USD","LU0320765992.SGD","CRL","LU0122379950.USD","LU1983299246.USD","LU2089984988.USD","BK4139","TBXU","LU0868494617.USD","BBH","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961345","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961345","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961345?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:10","pubTimestamp":1789643407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), Atricure (ATRC) and Stryker (SYK) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0690374615.EUR","BK4585","LU2242652126.USD","LU0528227936.USD","LU2506952097.USD","BK4566","LU2362541513.USD","LU0128526141.USD","BK4082","IE0002141913.USD","LABU","TBXU","LU2362540622.SGD","LU2089984988.USD","IHI","LU0823417653.USD","BK4581","LU0690374961.EUR","SYK","LU2404859741.USD","PJP","GB00B4LPDJ14.GBP","LU2362541273.HKD","LU0432979614.USD","BIB","LU2506951875.HKD","XLV","LU1571399168.USD","IBB","LU0029874061.USD","BK4534","LU0868494617.USD","IE00BJT1NW94.SGD","BBH","LU0109394709.USD","BK4599","PBE","XBI","GB00B4QBRK32.GBP","AMGN","BK4588","LU2468319806.SGD","HCSG","LU0882574055.USD","LU2324357040.USD","LU0058720904.USD","LU1061106388.HKD","ATRC","LU2404859667.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963550","title":"Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963550","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963550?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:31","pubTimestamp":1789637460,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia--Malaysian copper-composite manufacturer Vertex Material plans to go public in the U.S. next year after achieving a reported valuation of about $7 billion.The advanced-materials","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPXR","IDNA","VRTX","ICOP","IE00B2B36J28.USD","IE0002270589.USD","LU1430594728.SGD","BK4023","LU2237438978.USD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","LU0256863811.USD","VERX","IE00B19Z9Z06.USD","BK4139","IE00B19Z9P08.USD","COPP","IE0009355771.USD","LU2468319806.SGD","LU0823416689.USD","LU2324357040.USD","LU2462157665.USD","GNMX","BBH","IBBQ","XME","LU0320765992.SGD","LU0566484027.USD","COPJ","LU1035775433.USD","QCmain","LU2362541513.USD","LU2236285917.USD","BIB","LU1093756325.SGD","LU2417539215.USD","LU0889565916.HKD","UYM","CPER","BK4532","LU2089984988.USD","IBB","LU1778281490.HKD","MHGmain","TBXU","SG9999013999.USD","LU1069344957.HKD","LU0432979614.USD","PBE","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668593306","title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2668593306","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668593306?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:28","pubTimestamp":1789590524,"startTime":"0","endTime":"0","summary":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier sells USD 431,819 of common stockGilead: Chief Comm & Corp Aff Officer Johanna Mercier sold 3,000 common shares on Sep. 15, 20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL6sfPNq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU2087621335.USD","LU0289739699.SGD","LU1585245621.USD","MEDI","LU0109394709.USD","BBH","LU0122379950.USD","BK4550","LU0859254822.USD","IE0002270589.USD","IBBQ","BK4568","LU1674673428.USD","LU2089984988.USD","GILD","LU1674673691.USD","BK4566","BMED","LU0114720955.EUR","LU2357627491.SGD","BIB","IE00BSNM7G36.USD","LU1066053197.SGD","BK4588","IE00B19Z3B42.SGD","LU0965509283.SGD","BK4532","LU0882574055.USD","IE00B19Z3581.USD","TBXU","LU0965509101.SGD","LU0320765992.SGD","TMED","LU1023059063.AUD","IBB","LU1778281490.HKD","LU0234570918.USD","BK4578","SG9999015945.SGD","LU1430594728.SGD","BK4585","IE00BKVL7J92.USD","SG9999015986.USD","IE00B3T34201.USD","LU1066051498.USD","SG9999015952.SGD","LU0823416689.USD","LU2468319806.SGD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983112","title":"Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983112","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983112?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:30","pubTimestamp":1789561801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA4XXCG2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","LU0114720955.EUR","LU1571399168.USD","LU0234570918.USD","GILD","IE00BKVL7J92.USD","LU1023059063.AUD","LU1585245621.USD","SG9999015945.SGD","SG9999015952.SGD","IBB","LU1057294990.SGD","IE00B19Z3581.USD","MEDI","LU0965509283.SGD","BIB","SG9999015978.USD","IBBQ","BK4550","LU1839511570.USD","LU2112291526.USD","LU1037948897.HKD","BBH","BK4568","LU0965509101.SGD","LU1934455863.HKD","IE00B7SZLL34.SGD","LU0122379950.USD","LU2324357040.USD","TBXU","TMED","LU0058720904.USD","LU1037948541.HKD","LU2089984988.USD","LU0859254822.USD","LU2357627491.SGD","BMED","LU0109394709.USD","IE00BSNM7G36.USD","LU0965509010.AUD","LU1934455277.USD","LU1066053197.SGD","IE00BZ1G4Q59.USD","LU1061106388.HKD","LU1430594728.SGD","LU2087621335.USD","LU0823416689.USD","LU0882574055.USD","IE00B3T34201.USD","LU0861579265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667979600","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667979600","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667979600?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU1069344957.HKD","IE00BJJMRZ35.SGD","IDNA","VRTX","BIB","LABU","IE00B894F039.SGD","GNMX","CRL","LU0390134368.USD","IE00BZ9MQY76.HKD","LU2362541273.HKD","XLV","BBH","LU2362540622.SGD","LU0109394709.USD","LU1585245621.USD","LU0289739699.SGD","MEDI","XBI","SGXZ57979304.SGD","LU2324357040.USD","IE0009355771.USD","IBBQ","LU0029874061.USD","LU1430594728.SGD","LU1093756168.USD","LU2237438978.USD","VERX","LU0061475181.USD","BK4585","LU1093756325.SGD","LU1559883803.SGD","LU2462157665.USD","BK4023","LU2236285917.USD","IBB","BK4533","LU0889565916.HKD","TBXU","LU2417539215.USD","BK4588","BK4581","HCSG","LU0757428866.USD","LU1035775433.USD","LU1778281490.HKD","ASND","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667600950","title":"The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2667600950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667600950?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557600,"startTime":"0","endTime":"0","summary":"T. Rowe Price manager looks for trouble to find his global value betsT.Rowe Price manager Sebastien Mallet is betting on more than technology for his five-star fund.One secret to global value manager Sebastien Mallet's success?","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000304797.USD","LU0496365809.HKD","BK4605","SKHL","LU0211326839.USD","LU2106854487.HKD","LU0208291251.USD","LU2177674079.SGD","BMED","LU0211331839.USD","BK4007","LU0889566641.SGD","LU0006306889.USD","LU0882574139.USD","SG9999004303.SGD","INYY","LU0823421416.USD","LU0082616367.USD","IE00BYXW3230.USD","LU2461242641.AUD","SKHZ","BKNG","LU0133085943.USD","LU0889565916.HKD","LU0820561818.USD","LU0234570918.USD","LU0323591593.USD","SG9999015978.USD","IE000SO60NU8.SGD","SIL","SKHX","SLVR","LU2168564222.USD","LU1366333091.USD","LU0823413660.USD","LU2236285917.USD","LU0266013472.USD","LU0432979614.USD","AMDG","LU0316494557.USD","LU0683600562.USD","LU0965509283.SGD","LU2357627491.SGD","LU0256863811.USD","LU0345770308.USD","SGXZ23171101.USD","SG9999002224.SGD","WISE","LU0390134368.USD","BK4614","LU0029864427.USD","SINTCmain","LU0154236417.USD","LU0345769631.USD","LU0251142724.SGD","BK4535","LU0823434583.USD","SKHY","LU0157215616.USD","AMYY","LU1956131251.USD","IE00BQXX3C00.GBP","IE00BDCRKT87.USD","LU0106261372.USD","LU2250418816.HKD","LU0127658192.USD","BK4612","LU2552382058.USD","WPM","SAMD0main","LU0256863902.USD","JPMO","IE00B5TLWC47.USD","LU0310800379.SGD","LU1496350171.SGD","INTW","LU1116320901.HKD","LU1066053197.SGD","LU0417517546.SGD","LU1242518931.SGD","LU1244550494.USD","SMHX","LU0820561909.HKD","AIS","LU0114720955.EUR","LU2148611432.USD","IE00B1BXHZ80.USD","LU2211815571.USD","JBHT","IE00BLSP4452.SGD","LU1720051017.SGD","LU1917777945.USD","SKHQ","BK4534","LU1861215975.USD","LU2054465674.USD","LU0203345920.USD","LU2931357623.SGD","LU2237443465.HKD","LU2355687059.USD","LU0823413587.USD","BK4232","IE0034235303.USD","LU0081259029.USD","LU2290526834.HKD","IE00BJTD4N35.SGD","LU2108987350.USD","LU0345774391.USD","SKUU","BK4554","LU0321505439.SGD","LU1988902786.USD","AMDY","WNDR","LU0868494617.USD","04335","BK4533","IXG","LU0868494708.USD","AMDU","LU0719512351.SGD","LU0882574055.USD","LU2746668974.SGD","LU0823416689.USD","LU0128525929.USD","BK4578","LU1670627923.USD","INT","BK4561","IE00BJTD4V19.USD","LU0077335932.USD","BK4022","HK0000304805.HKD","BKNU","LU2756315318.SGD","LU0353189763.USD","LU0654597011.USD","LU0792757196.USD","IE00BZ1G4Q59.USD","07709","LU1974910355.USD","LU2592432038.USD","LU0320765992.SGD","LU1852331112.SGD","LU1914381329.SGD","LU1496350502.SGD","FMTL","LU1121112475.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","QQQA","SG9999002232.USD","SOXY","LU2505996509.AUD","LU0612318971.USD","LU1551013342.USD","LU1861558580.USD","LU1934455277.USD","IE00B775SV38.USD","DAMD","LU2471134952.CNY","LU0187121727.USD","LU2896262040.SGD","LU1119994496.HKD","LU1674673428.USD","PSI","LU1551013425.SGD","ARTY","LU1023059063.AUD","IE000BZT7R73.USD","LU0210536198.USD","LU2750360997.AUD","LU1037948897.HKD","BK4581","KBWB","LU1674673691.USD","IE00BDRTCR15.USD","LU0965508806.USD","LU2471134796.USD","IE0002270589.USD","BK4585","LU1150488135.SGD","IE00B7SZLL34.SGD","LU0786609619.USD","AMUU","WUGI","IE00BK4W5M84.HKD","LU1232071149.USD","LU1244550577.SGD","GAMR","LU1064131342.USD","LU2764263203.CNY","BK4588","LU1145028129.USD","BK4548","SG9999001440.SGD","LU0109394709.USD","SG9999015986.USD","LU2750360641.GBP","LINT","BK4568","SKDD","IE0034235295.USD","LU1670628061.USD","SGXZ81514606.USD","LU1267930573.SGD","LU1829250122.USD","IYF","LU0787776722.HKD","LU1084165304.USD","LU0106831901.USD","BAI","HYNX","LU0964807845.USD","BK4515","SILJ","AMDS","LU1043141396.HKD","LU2720916845.USD","IE00BMPRXR70.SGD","LU1880398471.USD","LU2468319806.SGD","GILD","LU2357305700.SGD","LU1057294990.SGD","LU2089984988.USD","LU0048584097.USD","LU2430703251.USD","IE00BSNM7G36.USD","DRIV","LU1043141123.HKD","LU2237957811.SGD","LU0238689110.USD","LU0689472784.USD","BK4579","LU0943347566.SGD","LU1236620834.HKD","LU2112291526.USD","LU0122379950.USD","LU2860962120.EUR","LU2552382215.SGD","LU1699723380.USD","LU1280957306.USD","LU1066051498.USD","LU2324357040.USD","LU2168564149.EUR","IE00BKVL7J92.USD","LU2764262908.HKD","LU0823411888.USD","TBXU","LU1548497426.USD","LU0965509010.AUD","IE0009356076.USD","TFNS","BK4207","ILDR","XLF","LU0225283273.USD","FNCL","LU1236620750.USD","FNV","LU0149725797.USD","LU1629891620.HKD","IE00BKDWB100.SGD","LU0345769128.USD","LU0215105999.USD","LU0265550359.USD","LU0251132253.USD","AMDW","LU0321505868.SGD","LU2430703095.HKD","LU0861579265.USD","LU0211328371.USD","IE00B3T34201.USD","IE000F7OJYX1.SGD","LU2361045086.USD","TEK","LU2237443895.HKD","LU1267930490.SGD","LU0353189680.USD","FTXL","LU1861559042.SGD","LU2087621335.USD","LU1803068979.SGD","LU1242518857.USD","LU2237957902.USD","IE0034235188.USD","SG9999001424.SGD","IE00BMPRXQ63.HKD","LU0994945656.USD","IE00BN8TJ469.HKD","LU1162221912.USD","LU0859254822.USD","LU2264538146.SGD","BK4512","LU0612318385.USD","LU1894683348.USD","LU0823421333.USD","LU0070302665.USD","BK4504","LU2242649171.HKD","LU0426417589.USD","AZN","LU1804176565.USD","LU1037948541.HKD","LU0274383776.USD","LU0823434740.USD","IE000M9KFDE8.USD","LU2168563687.JPY","LU1116320737.USD","BK4543","LU1261432733.SGD","BK4550","BK4583","VFH","LU0320765489.SGD","IE00BQXX3D17.EUR","LU1989764748.USD","LU2505996681.GBP","LU0742534661.SGD","IE00BQXX3F31.USD","BK4573","LU2237443382.USD","GDX","LU0097036916.USD","IE00B5949003.HKD","CHAT","BK4532","LU1894683264.USD","LU2168564065.EUR","SKHA","IYG","IETC","LU1923623000.USD","CHPS","AMDD","LU2023250843.SGD","LU0267386448.USD","MEDI","BBH","BK4566","AIQ","LU2361044949.HKD","LU0965509101.SGD","LU1303367103.USD","SG9999015945.SGD","LU0203347892.USD","LU2023250504.SGD","SKHN","BK4520","LU2265009873.SGD","SG9999015952.SGD","LU1363072403.SGD","LU0048573561.USD","BK4567","LU2462157665.USD","LU1934455194.USD","BIB","AMDC","LU0211326755.USD","IE00B3S45H60.SGD","LU0640476718.USD","LU2360107168.USD","SK","GLDN","LU2381873111.SGD","TTEQ","LU2247934214.USD","IE00BHPRN162.USD","LU2552382132.HKD","BK4529","IE0001KFT4U8.USD","BK4142","LU0198837287.USD","TRFK","XNTK","IE00BJLML261.HKD","LU2458330169.SGD","LU2213496289.HKD","LU0823397285.USD","SKHYV","LU2097829019.USD","LU2244417387.USD","LU2756315664.SGD","IBBQ","LU0642271901.SGD","LU0979878070.USD","LU1934455863.HKD","LU0823397103.USD","LU0889565833.HKD","LU0251131958.USD","LU0345770993.USD","LU1989764664.SGD","LU2087625088.SGD","IE00BFXG1179.USD","LU2456880835.USD","LU1267930813.SGD","LU2168564495.EUR","LU1861220033.SGD","LU1244550221.USD","FAI","LU0708994859.HKD","LU2462591350.SGD","AWAY","BK4516","LU0310799852.SGD","BK4135","IE0004445239.USD","LU1880398554.USD","IE0000B7K699.USD","LU1720051108.HKD","AUAU","LU0942090050.USD","LU1585245621.USD","LU2237443549.SGD","LU2098885051.SGD","LU0320765646.SGD","LU2458330243.SGD","LU2764263039.SGD","LU0557290698.USD","IE00BMPRXN33.USD","TMED","LU0056508442.USD","LU0976567544.SGD","LU1032466523.USD","LU1951198990.SGD","AMDL","SMH","BK4139","IE00B1XK9C88.USD","IE000WAW04H5.SGD","IE00BK4W5L77.USD","LU1989772840.SGD","LU0289739699.SGD","CNAV","BK4527","FTXO","LU0211327993.USD","JPM","LU0174119429.USD","LU0170899867.USD","IE000MB6IJN5.SGD","LU0820562030.AUD","LU1316542783.SGD","LU1839511570.USD","LU2237443978.SGD","LU2360106780.USD","BK4602","INTC","GOAU","LU0234572021.USD","LU2471134879.HKD","LU1430594728.SGD","LU1951200564.SGD","LU1571399168.USD","LU0109392836.USD","LU1668664300.SGD","LU2008162690.USD","LU2543165471.USD","TROW","BK4141","IE00BWXC8680.SGD","LU1778281490.HKD","LEGR","LU1150488218.USD","LU0345774631.USD","LU0265550946.USD","AZNH","AMD","LU2089985449.USD","SGXZ51526630.SGD","UYG","LU1989772923.USD","SOXX","LU1061106388.HKD","LU2417539215.USD","SKHU","LU0426412945.USD","LU2237443622.USD","LU2023250330.USD","LU2361044865.SGD","USXF","JPO","LU0971096721.USD","LU1366192091.USD","BK4017","IE00BLSP4239.USD","TRUF","BK4575","LU2430703178.SGD","IBB","LU1430597077.USD","LU2471134523.USD","LU0058720904.USD","LU2746668461.USD","SGXZ99366536.SGD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607925","title":"Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607925","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607925?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556400,"startTime":"0","endTime":"0","summary":"Sling Therapeutics raises $123 million to advance thyroid eye disease drugSept 16 (Reuters)-Drug developer Sling Therapeutics said on Wednesday ithad raised $123 million to advance a late-stage trial ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4N457178:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU0320765992.SGD","LU2468319806.SGD","LU1571399168.USD","BK4585","IE00BFTCPJ56.SGD","LU1023059063.AUD","BK4534","IBB","LU1057294990.SGD","BIB","IBBQ","LU2242652126.USD","LU2112291526.USD","LU1983299246.USD","AMGN","BBH","IE00B4R5TH58.HKD","LU0889565916.HKD","IE0002141913.USD","BK4599","BK4581","LU0868494617.USD","LU0122379950.USD","IE00B2B36J28.USD","TBXU","LU0058720904.USD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU0109394709.USD","IE0009355771.USD","BK4139","IE00BJT1NW94.SGD","LU2242646821.SGD","VRDN","BK4533","LU1061106388.HKD","BK4588","SG9999001440.SGD","PJP","PBE","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667832674","title":"Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667832674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667832674?lang=en_us&edition=fundamental","pubTime":"2026-09-16 11:47","pubTimestamp":1789530442,"startTime":"0","endTime":"0","summary":"Rohto starts Phase II trial of RE-01 cell therapy for refractory ischemic leg ulcersRohto began CDMO manufacturing for RE-01 cell therapy used in a Phase II investigator-led trial for refractory ische","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDLJMrSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455277.USD","IBB","IE00BZ1G4Q59.USD","LU1674673691.USD","BK4578","LU0122379950.USD","LU2112291526.USD","BMED","LU0234570918.USD","LU1037948541.HKD","LU0823416689.USD","LU0289739699.SGD","LU0114720955.EUR","LU1585245621.USD","LU1066051498.USD","LU1839511570.USD","TMED","LU1066053197.SGD","SG9999015978.USD","LU2468319806.SGD","IE00BKVL7J92.USD","BK4532","LU2089984988.USD","LU2357627491.SGD","LU1778281490.HKD","BK4583","MEDI","LU1057294990.SGD","LU0965509283.SGD","LU1061106388.HKD","LU1037948897.HKD","LU0320765992.SGD","LU1934455194.USD","GILD","LU0058720904.USD","LU0889565916.HKD","IE00B7SZLL34.SGD","BIB","LU0861579265.USD","BBH","LU1430594728.SGD","BK4568","BK4550","LU1934455863.HKD","SG9999015986.USD","SG9999015945.SGD","LU0965509010.AUD","TBXU","IBBQ","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667624218","title":"Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2667624218","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667624218?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:25","pubTimestamp":1789503924,"startTime":"0","endTime":"0","summary":"UPDATE 1-Bristol Myers sues Amgen over proposed Opdivo biosimilarSept 15 (Reuters)-Bristol Myers SquibbBMY.Nand Ono Pharmaceutical4528.Thave sued AmgenAMGN.Oin Delaware federal court, seeking to block","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL6N457192:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU1571399168.USD","LU1061106388.HKD","TBXU","LU0225284248.USD","IBBQ","LU0868494617.USD","LU0237698245.USD","LU1585245621.USD","LU1883839398.USD","LU0061475181.USD","BMY","LU2596442595.SGD","LU0306806265.USD","BIB","LU1868836757.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU2112291526.USD","LU1868837136.USD","LU1236620834.HKD","FTXH","LU2468319806.SGD","IBB","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU2242646821.SGD","BK4532","LU0321505439.SGD","LU1670711040.USD","LU1718418525.SGD","LU1670710588.SGD","PBE","LU2242652126.USD","LU1093756168.USD","LU0267386448.USD","LU0432979614.USD","LU0058720904.USD","BK4533","IE00BFXG1179.USD","LU1670711123.USD","LU1323610961.USD","BK4588","LU1291159041.SGD","LU2125154778.USD","LU0109394709.USD","LU1868837300.USD","LU1430594728.SGD","BK4599","LU0122379950.USD","LU0114720955.EUR","LU1989771016.USD","IE00B4R5TH58.HKD","LU1032466523.USD","AMGN","LU1074936037.SGD","BK4559","IE00B2B36J28.USD","LU0096364046.USD","PJP","LU0289739699.SGD","LU1670710661.SGD","SG9999001440.SGD","BK4534","04332","BK4139","LU0456855351.SGD","IE0009355771.USD","LU1236620750.USD","BK4566","BK4007","LU1261432733.SGD","LU0225771236.USD","LU1868836591.USD","LU0882574055.USD","IHE","LU2125154935.USD","LU0306807586.USD","LU0889565916.HKD","LU0320765992.SGD","LU0321505868.SGD","LU2089984988.USD","BK4585","LU1023059063.AUD","BBH","LU1057294990.SGD","LU0985481810.HKD","LU1983299246.USD","LU2360032135.SGD","LU2133065610.SGD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1868836914.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667621483","title":"Revolution Medicines gets orphan designation for pancreatic cancer treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621483","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621483?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:00","pubTimestamp":1789498813,"startTime":"0","endTime":"0","summary":"The FDA granted Revolution Medicines (RVMD)’ zoldonrasib orphan designation as a treatment of pancreatic cancer. Published first on TheFly – the ul...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-gets-orphan-designation-for-pancreatic-cancer-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-gets-orphan-designation-for-pancreatic-cancer-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRZ35.SGD","IDNA","LU0320765992.SGD","LABU","BBH","LU0109394709.USD","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BFTCPJ56.SGD","RVMD","IE00B2B36J28.USD","BK4585","IE0002141913.USD","BK4139","IE0009354923.USD","LU0889565916.HKD","PTH","BK4588","IE00BJT1NW94.SGD","CANC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}